BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27634941)

  • 1. Glucocorticoid receptor haplotype and metabolic syndrome: the Lifelines cohort study.
    Wester VL; Koper JW; van den Akker EL; Franco OH; Stolk RP; van Rossum EF
    Eur J Endocrinol; 2016 Dec; 175(6):645-651. PubMed ID: 27634941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glucocorticoid receptor gene haplotype (TthIII1/ER22/23EK/9beta) is associated with a more aggressive disease course in multiple sclerosis.
    van Winsen LM; Manenschijn L; van Rossum EF; Crusius JB; Koper JW; Polman CH; Uitdehaag BM
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2110-4. PubMed ID: 19318444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemia.
    Koeijvoets KC; van der Net JB; van Rossum EF; Steyerberg EW; Defesche JC; Kastelein JJ; Lamberts SW; Sijbrands EJ
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4902-8. PubMed ID: 18812484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome.
    Kaya Z; Caglayan S; Akkiprik M; Aral C; Ozisik G; Ozata M; Ozer A
    J Endocrinol Invest; 2016 May; 39(5):557-66. PubMed ID: 26596278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthropometrics and Metabolic Syndrome in Relation to Glucocorticoid Receptor Polymorphisms in Corticosteroid Users.
    Savas M; Wester VL; van der Voorn B; Iyer AM; Koper JW; van den Akker ELT; van Rossum EFC
    Neuroendocrinology; 2021; 111(11):1121-1129. PubMed ID: 33311027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic glucocorticoid receptor variants differ between ethnic groups but do not explain variation in age of diabetes onset, metabolic and inflammation parameters in patients with type 2 diabetes.
    Ahdi M; Gerards MC; Smits PHM; Meesters EW; Brandjes DPM; Nieuwdorp M; Gerdes VEA
    Front Endocrinol (Lausanne); 2023; 14():1200183. PubMed ID: 37732126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing's syndrome.
    Roerink SH; Wagenmakers MA; Smit JW; van Rossum EF; Netea-Maier RT; Plantinga TS; Hermus AR
    Endocrine; 2016 Jul; 53(1):63-70. PubMed ID: 26873309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome.
    Trementino L; Appolloni G; Concettoni C; Cardinaletti M; Boscaro M; Arnaldi G
    Eur J Endocrinol; 2012 Jan; 166(1):35-42. PubMed ID: 22048965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in the glucocorticoid receptor gene (NR3C1) and cardiovascular disease risk. The Leiden 85-plus Study.
    Kuningas M; Mooijaart SP; Slagboom PE; Westendorp RG; van Heemst D
    Biogerontology; 2006 Aug; 7(4):231-8. PubMed ID: 16676134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPA axis dysregulation, NR3C1 polymorphisms and glucocorticoid receptor isoforms imbalance in metabolic syndrome.
    Martins CS; Elias D; Colli LM; Couri CE; Souza MC; Moreira AC; Foss MC; Elias LL; de Castro M
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27507764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid and mineralocorticoid receptor polymorphisms and recurrence of major depressive disorder.
    Hardeveld F; Spijker J; Peyrot WJ; de Graaf R; Hendriks SM; Nolen WA; Penninx BW; Beekman AT
    Psychoneuroendocrinology; 2015 May; 55():154-63. PubMed ID: 25765757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome.
    Teeninga N; Kist-van Holthe JE; van den Akker EL; Kersten MC; Boersma E; Krabbe HG; Knoers NV; van der Heijden AJ; Koper JW; Nauta J
    Kidney Int; 2014 Jun; 85(6):1444-53. PubMed ID: 24429396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
    Das A; Khurshid S; Hayat S; Ahmed R; Islam Z
    J Neuroimmunol; 2020 Nov; 348():577388. PubMed ID: 32949992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome in anti-neutrophil cytoplasmic antibody-associated vasculitis and gene variants of 11β-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptor.
    Hessels AC; Tuin J; Sanders JSF; Huitema MG; van Rossum EFC; Koper JW; van Beek AP; Stegeman CA; Rutgers A
    Rheumatology (Oxford); 2019 Mar; 58(3):447-454. PubMed ID: 30445609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis.
    Quax RA; Koper JW; Huisman AM; Weel A; Hazes JM; Lamberts SW; Feelders RA
    Rheumatol Int; 2015 Aug; 35(8):1325-33. PubMed ID: 25724472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor and molecular chaperones in the pathogenesis of adrenal incidentalomas: potential role of reduced sensitivity to glucocorticoids.
    Damjanovic SS; Antic JA; Ilic BB; Cokic BB; Ivovic M; Ognjanovic SI; Isailovic TV; Popovic BM; Bozic IB; Tatic S; Matic G; Todorovic VN; Paunovic I
    Mol Med; 2013 Jan; 18(1):1456-65. PubMed ID: 23196783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the Heart and Soul study.
    Otte C; Wüst S; Zhao S; Pawlikowska L; Kwok PY; Whooley MA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2885-91. PubMed ID: 20371666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in men.
    van Raalte DH; van Leeuwen N; Simonis-Bik AM; Nijpels G; van Haeften TW; Schafer SA; Boomsma DI; Kramer MH; J Heine R; Maassen JA; Staiger H; Machicao F; Häring HU; Slagboom PE; Willemsen G; de Geus EJ; Dekker JM; Fritsche A; Eekhoff EM; Diamant M; 't Hart LM
    Diabet Med; 2012 Aug; 29(8):e211-6. PubMed ID: 22507373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms.
    Sivapalan P; Borresen SW; Eklöf J; Klose M; Holm FS; Feldt-Rasmussen U; Rossing M; Jørgensen NR; Marvig RL; Saeed MI; Wilcke T; Seersholm N; Mathioudakis AG; Vestbo J; Jensen JS
    PLoS One; 2022; 17(2):e0262898. PubMed ID: 35120172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid receptor polymorphism BclI with increased glucocorticoid sensitivity has a positive influence on quality of life in endogenous Cushing's syndrome in remission.
    Feldkamp L; Müller L; Deutschbein T; Detomas M; Hahner S; Strasburger CJ; Künzel H; Oßwald A; Braun L; Rubinstein G; Reincke M; Quinkler M; Kienitz T
    Eur J Endocrinol; 2023 Apr; 188(4):366-374. PubMed ID: 36995896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.